Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Houston biotech co.’s coronavirus treatment candidate to undergo clinical trials

Posted on March 30, 2020 by Brenton Scott
Posted in News Coverage

Post navigation

Houston researchers test lung inhalant that could protect healthcare workers from COVID-19
Houston company working on possible COVID-19 treatment
Pulmotect Inc

10401 Town Park Drive
Houston, TX 77072
Contact Us

© 2026
Pulmotect, Inc.